Moleculin announces reverse stock split

Moleculin Biotech will effect a 1-for-20 reverse stock split on Oct. 20, 2026, reducing outstanding shares from ~20.9M to ~1.05M; no fractional shares will be issued.Material DetailsContext by AI AnalystThis is a late-stage move consistent with micro-cap biotechs seeking Nasdaq listing compliance a…